Arhaus (ARHS) Q1 2026 earnings review
Record Top Line Masks Collapsing Demand and Profits
Management touted 'the highest first-quarter net revenue in Arhaus history,' but the underlying financials tell a significantly weaker story. Revenue barely crept up 0.9%, while Net Income plunged 54.5% to $2 million. The most troubling metric is Comparable Written Sales, which dropped 5.7%, indicating that order intake is deteriorating rapidly under macroeconomic pressure. Operating leverage has reversed entirely: SG&A grew faster than sales, and gross margins compressed by 100 basis points. While liquidity remains strong (aided by a recent $49 million special dividend), Arhaus is entering a tough Q2 comparison with weakening forward momentum.
๐ Bull Case
The company is plowing ahead with 10-14 new Showroom projects this year. Their cash-rich, debt-free balance sheet allows them to capture market share while weaker competitors retreat.
Current guidance explicitly excludes potential refunds from IEEPA tariffs. If realized, this could provide an unexpected, high-margin windfall later in the year.
๐ป Bear Case
Comparable Written Sales fell 5.7%. The 'resilient' high-end consumer is clearly pulling back, creating a revenue vacuum that will eventually hit the P&L.
Gross margin dropped 100 bps, and Adjusted EBITDA fell 3.1%. The company is struggling to manage its fixed costs in a decelerating sales environment.
โ๏ธ Verdict: ๐ด
Bearish. Management's rosy narrative directly contradicts the underlying data. When Written Sales drop nearly 6% and operating cash flow turns negative, touting 'record Q1 revenue' (up less than 1%) is a distraction from rapidly eroding fundamentals.
Key Themes
Contradicting the Narrative: Written Demand is Decelerating
Management praised the 'resilience of our client base,' yet Comparable Written Sales declined 5.7%. This metric acts as a leading indicator for future revenue. While Delivered Sales only dipped 1.7% as the company worked through backlog, the sharp drop in new orders strongly contradicts the company's upbeat tone regarding consumer health.
Operating Cash Flow Reverses to Negative
Arhaus burned $10 million in operating cash this quarter, a drastic reversal from the $46.5 million generated in 25Q1. This was primarily driven by a 54% plunge in Net Income, a $30.6 million build in inventory, and decreasing accounts payable. Managing working capital in a declining demand environment will be a critical test for the remainder of the year.
Margin Squeeze Accelerating
Gross margin dropped 100 basis points to 36.4% (down from 37.1% in 25Q1). Simultaneously, SG&A grew 1.9% on just 0.9% revenue growth, destroying operating leverage. If Written Sales remain negative, this fixed-cost deleverage will severely threaten the company's ability to hit its full-year EBITDA target of $150-$161 million.
Showroom Footprint Expansion
Physical expansion remains the primary structural growth driver. Arhaus opened a new Traditional Showroom in Ashburn, VA, and expanded in Park Meadows, CO. The company reaffirmed its target of 10-14 total projects for FY26 (yielding mid-single-digit net unit growth). This footprint expansion is necessary to offset the negative comparable sales.
ERP and Technology Upgrades
Arhaus continues to invest in technology infrastructure, specifically noting the rollout of a new enterprise resource planning (ERP) system. While listed as a risk factor, this technology modernization is a required structural innovation to scale the business, improve inventory visibility, and eventually drive back-office SG&A leverage.
Potential IEEPA Tariff Refund Catalyst
A newly introduced catalyst: the potential for IEEPA tariff refunds. Management explicitly stated that their current outlook does not include any benefit from these potential refunds. Given that Arhaus historically faced massive tariff headwinds ($50-$60M annualized in previous estimates), any successful refund claim would drop straight to the bottom line.
Macroeconomic Uncertainty Limits Visibility
The macro environment continues to act as a heavy anchor. Management specifically blamed 'broader macro uncertainty' for near-term pressure on Written Sales. The company expects heavy reliance on the back half of the year to meet its reaffirmed guidance, which introduces significant macroeconomic execution risk.
Other KPIs
Decelerating. Gross margin contracted by 100 basis points year-over-year. This indicates a deteriorating pricing environment, higher supply chain costs, or negative fixed-cost leverage on nearly flat sales volume.
Accelerating. Client deposits (a proxy for order backlog) increased 15.0% from December 31, 2025. While higher deposits look positive, when paired with a 5.7% drop in Written Sales, it suggests the company is simply taking longer to fulfill the orders it does have, rather than generating a rapidly growing pipeline.
Accelerating. Inventory increased 9.0% from year-end 2025. A growing inventory pile alongside shrinking Written Sales is a classic retail red flag, elevating the risk of future markdowns and promotional pricing.
Guidance
Decelerating. The midpoint ($360M) implies virtually flat growth (+0.4%) compared to the $358.4M delivered in 25Q2. Management blames the tough comparison on last year's 'ahead of schedule' ramp of the Dallas Distribution Center.
Reversing. The midpoint of $21.5M implies a brutal 38.6% drop from 25Q2's $35.1M. This starkly illustrates the continuing margin compression and fixed-cost deleverage.
Stable. Maintained full-year guidance implies 3.7% to 6.6% growth. However, given the weak Q1 and flat Q2 outlook, achieving this requires a significant and risky re-acceleration in the second half of the year.
Stable. The company is banking on new showroom openings to drive total revenue, as comparable sales are expected to be roughly flat.
Key Questions
Second Half Re-acceleration
With Q1 revenue up just 0.9% and Q2 guided essentially flat, your maintained FY26 guidance requires a significant re-acceleration in the back half. What specific leading indicators give you confidence in this H2 hockey stick?
Gross Margin Contraction
Gross margin compressed by 100 basis points this quarter. How much of this was driven by fixed-cost deleverage versus higher product/freight costs, and what is the exact bridge to recovering this margin later in the year?
Inventory vs. Demand Dynamics
Inventories grew 9% sequentially while Written Sales fell nearly 6%. Are you purposely building inventory to front-run potential supply chain disruptions, or is this a sign of unexpected demand shortfall?
IEEPA Tariff Refund Quantification
You noted that guidance excludes potential IEEPA tariff refunds. Can you bracket the potential size of this opportunity and the expected timeline for resolution?
